Liaoning Kelong Fine Chemical, Inc. (SHE:300405)
China · Delayed Price · Currency is CNY 5.86
-0.09 (-1.51%)
Sep 30, 2026, 3:04 PM CST
SHE:300405 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 595.75 | 542.74 | 629.13 | 555.83 | 775.95 | 1,082 |
Other Revenue | 8.82 | 0.89 | 2.7 | 2.36 | 4.3 | 6.81 |
| 604.57 | 543.63 | 631.83 | 558.2 | 780.25 | 1,089 | |
Revenue Growth | 4.02% | -13.96% | 13.19% | -28.46% | -28.34% | 17.22% |
Cost of Revenue | 558.4 | 518.01 | 589.64 | 535 | 773.96 | 935.24 |
Gross Profit | 46.17 | 25.62 | 42.19 | 23.2 | 6.29 | 153.53 |
Selling, General & Admin | 49.53 | 53.99 | 51.56 | 64.46 | 70.73 | 75.43 |
Research & Development | 7.4 | 7.7 | 9.03 | 9.09 | 13.09 | 10.59 |
Other Operating Expenses | 2.58 | -0.1 | 6.42 | 5.59 | 5.97 | 8.12 |
Operating Expenses | 58.75 | 70.35 | 73.7 | 105.47 | 150.26 | 113.16 |
Operating Income | -12.58 | -44.73 | -31.51 | -82.27 | -143.97 | 40.36 |
Interest Expense | -17.97 | -19.68 | -28.72 | -27.29 | -27.72 | -31.82 |
Interest & Investment Income | 0.53 | 0.76 | 1.6 | 3.2 | 21.66 | 3.02 |
Currency Exchange Gain (Loss) | -1.44 | -0.32 | 0.49 | 0.25 | 1.46 | -0.65 |
Other Non Operating Income (Expenses) | -4.06 | -4.84 | 0.09 | -1.84 | -8.16 | -1.74 |
EBT Excluding Unusual Items | -35.53 | -68.8 | -58.05 | -107.96 | -156.73 | 9.17 |
Impairment of Goodwill | - | - | - | - | -0.2 | - |
Gain (Loss) on Sale of Investments | -1.21 | -1.05 | -0.96 | -0.69 | - | -4.12 |
Gain (Loss) on Sale of Assets | -0.02 | 0.16 | 0.37 | 0.03 | 0.03 | 0 |
Asset Writedown | -3.49 | -1.44 | -16.52 | -3.59 | -2.05 | -0.26 |
Other Unusual Items | 2.29 | -1.59 | 19.58 | 18.03 | 6.88 | 3.25 |
Pretax Income | -37.96 | -72.73 | -55.59 | -94.17 | -152.08 | 8.04 |
Income Tax Expense | -7.56 | -11.36 | -5.78 | 6.13 | -33.35 | -7.37 |
Earnings From Continuing Operations | -30.4 | -61.38 | -49.81 | -100.3 | -118.73 | 15.41 |
Minority Interest in Earnings | 0.39 | 0.16 | -0.02 | 0.07 | -0.03 | -3.49 |
Net Income | -30.01 | -61.21 | -49.83 | -100.23 | -118.75 | 11.92 |
Net Income to Common | -30.01 | -61.21 | -49.83 | -100.23 | -118.75 | 11.92 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 284 | 284 | 284 | 288 | 289 | 289 |
Shares Outstanding (Diluted) | 284 | 284 | 284 | 288 | 289 | 289 |
Shares Change | -0.12% | -0.04% | -1.24% | -0.41% | -0.07% | 0.07% |
EPS (Basic) | -0.11 | -0.22 | -0.18 | -0.35 | -0.41 | 0.04 |
EPS (Diluted) | -0.11 | -0.22 | -0.18 | -0.35 | -0.41 | 0.04 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | -105.13 | -68.95 | 19.09 | -15.47 | -121.89 | -4.83 |
Free Cash Flow Per Share | -0.37 | -0.24 | 0.07 | -0.05 | -0.42 | -0.02 |
Dividend Per Share | - | - | - | - | - | 0.023 |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 7.64% | 4.71% | 6.68% | 4.15% | 0.81% | 14.10% |
Operating Margin | -2.08% | -8.23% | -4.99% | -14.74% | -18.45% | 3.71% |
Profit Margin | -4.96% | -11.26% | -7.89% | -17.96% | -15.22% | 1.09% |
Free Cash Flow Margin | -17.39% | -12.68% | 3.02% | -2.77% | -15.62% | -0.44% |
EBITDA | 24.37 | -8.28 | 6.99 | -38.79 | -95.97 | 85.34 |
EBITDA Margin | 4.03% | -1.52% | 1.11% | -6.95% | -12.30% | 7.84% |
D&A For EBITDA | 36.95 | 36.46 | 38.5 | 43.49 | 48 | 44.98 |
EBIT | -12.58 | -44.73 | -31.51 | -82.27 | -143.97 | 40.36 |
EBIT Margin | -2.08% | -8.23% | -4.99% | -14.74% | -18.45% | 3.71% |
Revenue as Reported | 605.25 | 544.26 | 632.2 | 558.45 | 781.23 | 1,089 |